EcoDrugPlus

Cell Division Cycle 7

Ensembl ID : ENSDORG00000014664
Gene Symbol: CDC7
4 Cross references
209 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSDORG00000013040
Gene Symbol: CHEK1
4 Cross references
179 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSDORG00000009151
Gene Symbol: CHEK2
3 Cross references
206 Possible Orthologues:

Chemokine (C-X-C Motif) Receptor 1

Ensembl ID : ENSDORG00000015675
Gene Symbol: CXCR1
1 Cross references
230 Possible Orthologues:

Chemokine (C-X-C Motif) Receptor 4

Ensembl ID : ENSDORG00000014745
Gene Symbol: CXCR4
1 Cross references
218 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSDORG00000006353
Gene Symbol: CCKAR
4 Cross references
201 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSDORG00000013978
Gene Symbol: CCKBR
3 Cross references
270 Possible Orthologues:

Cholesterol 24-Hydroxylase

Ensembl ID : ENSDORG00000016258
Gene Symbol: LOC105984431
4 Cross references
260 Possible Orthologues:

Cholinergic Receptor Muscarinic 1

Ensembl ID : ENSDORG00000014333
Gene Symbol: CHRM1
4 Cross references
104 Possible Orthologues:

Cholinergic Receptor Muscarinic 2

Ensembl ID : ENSDORG00000006528
Gene Symbol: CHRM2
4 Cross references
261 Possible Orthologues:

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSDORG00000012022
Gene Symbol: CHRM3
4 Cross references
257 Possible Orthologues:

Cholinergic Receptor Muscarinic 4

Ensembl ID : ENSDORG00000024984
Gene Symbol: CHRM4
4 Cross references
186 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).